Sphera Funds Management Ltd. Fusion Pharmaceuticals Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.9 - $21.32 $5.03 Million - $13.6 Million	-636,598 Reduced 58.64%	449,041 $9.57 Million
Q4 2023 Feb 14, 2024	SELL	$2.48 - $9.65 $666,175 - $2.59 Million	-268,619 Reduced 19.84%	1,085,639 $10.4 Million
Q3 2023 Nov 14, 2023	BUY	$2.37 - $4.63 $59,250 - $115,750	25,000 Added 1.88%	1,354,258 $3.52 Million
Q2 2023 Aug 14, 2023	BUY	$3.47 - $5.33 $158,651 - $243,692	45,721 Added 3.56%	1,329,258 $6.21 Million
Q1 2023 May 15, 2023	BUY	$3.03 - $5.13 $3.89 Million - $6.58 Million	1,283,537 New	1,283,537 $4.84 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.